Post-earnings recap
Reported
Tue, May 4, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported a loss per share of $0.26, significantly missing expectations. The stock reacted negatively, dropping 5.35%. The lack of revenue figures and management commentary leaves investors without additional context for the results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.26 | N/A | -195.45% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results. Management's commentary and insights are not available.